Advertisement
News
Advertisement

Vertex stock tanks on swing to red

Fri, 11/02/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Vertex Pharmaceuticals (Nasdaq: VRTX) shares were down almost 13 percent Friday after the company reported a loss for the third quarter and weaker-than-expected sales of its approved therapies for hepatitis C and cystic fibrosis.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading